{"id":"https://openalex.org/W7207611980","doi":"https://doi.org/10.58175/gjrcp.2026.5.3.0092","title":"NEUROPROTECTIVE SECONDARY METABOLITES: MECHANISMS AND THERAPEUTIC POTENTIAL IN NEURODEGENERATIVE DISEASES","display_name":"NEUROPROTECTIVE SECONDARY METABOLITES: MECHANISMS AND THERAPEUTIC POTENTIAL IN NEURODEGENERATIVE DISEASES","alternate_titles":[],"publication_year":2026,"publication_date":"2026-07-31","ids":{"openalex":"https://openalex.org/W7207611980","doi":"https://doi.org/10.58175/gjrcp.2026.5.3.0092"},"language":"en","primary_location":{"id":"doi:10.58175/gjrcp.2026.5.3.0092","doi":"https://doi.org/10.58175/gjrcp.2026.5.3.0092","is_oa":true,"landing_page_url":"https://doi.org/10.58175/gjrcp.2026.5.3.0092","pdf_url":"https://gsjournals.com/gjrcp/sites/default/files/fulltext_pdf/GJRCP-2026-0092.pdf","source":{"id":"https://openalex.org/S4404675225","display_name":"Global journal of research in chemistry and pharmacy","issn_l":"2980-4213","issn":["2980-4213"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4404680328","host_organization_name":"Global Scholar Publications","host_organization_lineage":["https://openalex.org/P4404680328"],"host_organization_lineage_names":["Global Scholar Publications"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Global Journal of Research in Chemistry and Pharmacy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7207611980"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://gsjournals.com/gjrcp/sites/default/files/fulltext_pdf/GJRCP-2026-0092.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5149495140","display_name":"Moses Okpata Chukwuebuka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45711476","display_name":"Obafemi Awolowo University","ror":"https://ror.org/04snhqa82","country_code":"NG","type":"education","lineage":["https://openalex.org/I45711476"]}],"countries":["NG"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Moses Okpata Chukwuebuka","raw_affiliation_strings":["Department of Clinical Pharmacy , Obafemi Awolowo University , Ile-Ife , Osun State , Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy , Obafemi Awolowo University , Ile-Ife , Osun State , Nigeria","institution_ids":["https://openalex.org/I45711476"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5149495140"],"corresponding_institution_ids":["https://openalex.org/I45711476"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"3","first_page":"001","last_page":"011"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12891","display_name":"Medicinal Plants and Neuroprotection","score":0.9053000211715698,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12891","display_name":"Medicinal Plants and Neuroprotection","score":0.9053000211715698,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.06030000001192093,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plant-secondary-metabolites","display_name":"plant secondary metabolites","score":0.7990000247955322},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.9940000176429749},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/cerebral-ischemia","display_name":"cerebral ischemia","score":1.0},{"id":"https://openalex.org/keywords/huperzine-a","display_name":"huperzine A","score":0.8939999938011169},{"id":"https://openalex.org/keywords/curcumin","display_name":"curcumin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/resveratrol","display_name":"resveratrol","score":1.0},{"id":"https://openalex.org/keywords/epigallocatechin-gallate","display_name":"epigallocatechin gallate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ginsenosides","display_name":"ginsenosides","score":1.0},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibition","display_name":"acetylcholinesterase inhibition","score":0.9409999847412109},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8149999976158142},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/mitochondrial-dysfunction","display_name":"mitochondrial dysfunction","score":0.8299999833106995},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9639999866485596},{"id":"https://openalex.org/keywords/polyphenols","display_name":"polyphenols","score":0.8989999890327454},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.828000009059906},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8130000233650208},{"id":"https://openalex.org/keywords/natural-products","display_name":"natural products","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.9350000023841858},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6829000115394592},{"id":"https://openalex.org/C128188215","wikidata":"https://www.wikidata.org/wiki/Q3026765","display_name":"Neuropharmacology","level":2,"score":0.664900004863739},{"id":"https://openalex.org/C2778250585","wikidata":"https://www.wikidata.org/wiki/Q312266","display_name":"Curcumin","level":2,"score":0.5813000202178955},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.5103999972343445},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5098000168800354},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.4828000068664551},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46889999508857727},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.4546999931335449},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4526999890804291},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3237000107765198},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3167000114917755},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.29589998722076416},{"id":"https://openalex.org/C28859421","wikidata":"https://www.wikidata.org/wiki/Q39572","display_name":"Mitochondrion","level":2,"score":0.2930000126361847},{"id":"https://openalex.org/C2776409846","wikidata":"https://www.wikidata.org/wiki/Q425198","display_name":"Huperzine A","level":4,"score":0.2797999978065491},{"id":"https://openalex.org/C2993043200","wikidata":"https://www.wikidata.org/wiki/Q7239206","display_name":"Preclinical research","level":2,"score":0.27950000762939453},{"id":"https://openalex.org/C2780647506","wikidata":"https://www.wikidata.org/wiki/Q190564","display_name":"Huntington's disease","level":3,"score":0.2745000123977661},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.2660999894142151}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.58175/gjrcp.2026.5.3.0092","doi":"https://doi.org/10.58175/gjrcp.2026.5.3.0092","is_oa":true,"landing_page_url":"https://doi.org/10.58175/gjrcp.2026.5.3.0092","pdf_url":"https://gsjournals.com/gjrcp/sites/default/files/fulltext_pdf/GJRCP-2026-0092.pdf","source":{"id":"https://openalex.org/S4404675225","display_name":"Global journal of research in chemistry and pharmacy","issn_l":"2980-4213","issn":["2980-4213"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4404680328","host_organization_name":"Global Scholar Publications","host_organization_lineage":["https://openalex.org/P4404680328"],"host_organization_lineage_names":["Global Scholar Publications"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Global Journal of Research in Chemistry and Pharmacy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.58175/gjrcp.2026.5.3.0092","doi":"https://doi.org/10.58175/gjrcp.2026.5.3.0092","is_oa":true,"landing_page_url":"https://doi.org/10.58175/gjrcp.2026.5.3.0092","pdf_url":"https://gsjournals.com/gjrcp/sites/default/files/fulltext_pdf/GJRCP-2026-0092.pdf","source":{"id":"https://openalex.org/S4404675225","display_name":"Global journal of research in chemistry and pharmacy","issn_l":"2980-4213","issn":["2980-4213"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4404680328","host_organization_name":"Global Scholar Publications","host_organization_lineage":["https://openalex.org/P4404680328"],"host_organization_lineage_names":["Global Scholar Publications"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Global Journal of Research in Chemistry and Pharmacy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7207611980.pdf","grobid_xml":"https://content.openalex.org/works/W7207611980.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W4388561607","https://openalex.org/W4389210150"],"related_works":["https://openalex.org/W4416260371","https://openalex.org/W7124146640","https://openalex.org/W4413772920","https://openalex.org/W7124167313","https://openalex.org/W4415538432","https://openalex.org/W4410430112","https://openalex.org/W4324121910","https://openalex.org/W4392257808","https://openalex.org/W7204537760","https://openalex.org/W7149956633"],"abstract_inverted_index":{"Neurodegenerative":[0],"diseases,":[1],"including":[2,70,130,154],"Alzheimer's":[3,117],"disease":[4,7],"(AD),":[5],"Parkinson's":[6,119],"(PD),":[8],"and":[9,34,56,78,96,101,121,126,132,159,168],"cerebral":[10,122],"ischemia,":[11,123],"represent":[12],"an":[13],"escalating":[14],"global":[15],"health":[16],"crisis":[17],"with":[18],"limited":[19],"effective":[20],"therapies.":[21],"The":[22],"multifactorial":[23],"pathogenesis":[24],"of":[25,66,103,113],"these":[26,114],"disorders,":[27],"encompassing":[28],"protein":[29,104],"aggregation,":[30],"oxidative":[31],"stress,":[32],"neuroinflammation,":[33],"mitochondrial":[35,99],"dysfunction,":[36],"necessitates":[37],"therapeutic":[38,111],"approaches":[39],"that":[40],"target":[41],"multiple":[42],"pathways.":[43,106],"Plant":[44],"secondary":[45,68],"metabolites":[46],"have":[47],"emerged":[48],"as":[49],"promising":[50,144,151],"neuroprotective":[51,174],"agents,":[52],"offering":[53],"multi-targeted":[54],"mechanisms":[55,83],"favorable":[57],"safety":[58],"profiles.":[59],"This":[60,163],"review":[61,164],"comprehensively":[62],"examines":[63],"the":[64,110,139],"neuropharmacology":[65],"key":[67],"metabolites,":[69],"huperzine":[71],"A,":[72],"curcumin,":[73],"resveratrol,":[74,133],"epigallocatechin":[75],"gallate":[76],"(EGCG),":[77],"ginsenosides,":[79],"focusing":[80],"on":[81,138],"their":[82],"against":[84],"neurodegeneration.":[85],"We":[86],"critically":[87],"evaluate":[88],"evidence":[89],"for":[90,146,172,177],"neuroprotection":[91],"through":[92],"acetylcholinesterase":[93],"inhibition,":[94],"antioxidant":[95],"anti-inflammatory":[97],"effects,":[98],"protection,":[100],"modulation":[102],"aggregation":[105],"Furthermore,":[107],"we":[108],"assess":[109],"potential":[112],"compounds":[115],"in":[116],"disease,":[118,120],"evaluating":[124],"preclinical":[125],"clinical":[127,160,178],"evidence.":[128],"Polyphenols,":[129],"curcumin":[131],"exert":[134],"significant":[135],"inhibitory":[136],"effects":[137],"NF-\u03baB":[140],"pathway,":[141],"making":[142],"them":[143],"candidates":[145],"treating":[147],"neurological":[148],"disorders.":[149],"Despite":[150],"findings,":[152],"challenges":[153],"bioavailability,":[155],"blood-brain":[156],"barrier":[157],"penetration,":[158],"translation":[161],"persist.":[162],"identifies":[165],"research":[166],"gaps":[167],"discusses":[169],"emerging":[170],"strategies":[171],"optimizing":[173],"natural":[175],"products":[176],"application.":[179]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7207611980","counts_by_year":[],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2026-09-04T00:00:00"}
